Trexquant Investment’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Trexquant Investment’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-28,868	Closed	-$576K	–	1855
2022 Q3	$576K	Sell	28,868 -447	-2%	-$5.89K	0.02%	753
2022 Q2	$202K	Buy	+29,315	New	+$206K	0.01%	1353
2022 Q1	–	Sell	-26,415	Closed	-$376K	–	1857
2021 Q4	$376K	Buy	26,415 +17,489	+196%	+$303K	0.02%	799
2021 Q3	$207K	Buy	+8,926	New	+$211K	0.02%	948
2021 Q1	–	Sell	-10,958	Closed	-$382K	–	1594
2020 Q4	$382K	Buy	+10,958	New	+$477K	0.04%	557

Trexquant Investment's FMTX Position: Q4 2022 in Review

Trexquant Investment sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 28,868 shares — an estimated $576K sold.

Trexquant Investment first reported a position in FMTX in Q4 2020 and held it in 5 quarters. The position peaked at $576K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Trexquant Investment reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Trexquant Investment sold 28,868 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $576K.
Trexquant Investment first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
Trexquant Investment's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $576K in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Trexquant Investment's 13F filing for Q4 2022, filed 13 Feb 2023.